866-997-4948(US-Canada Toll Free)

HTG Molecular Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update

Published By :

GlobalData

Published Date : Sep 2014

Category :

Molecular Diagnostics

No. of Pages : 29 Pages


HTG Molecular Diagnostics, Inc. (HTG) is a technology service provider. The company provides molecular-technology solutions. It provides services to biomarker discovery and companion diagnostic developers. The companys HTG Molecular Diagnostics EDGE system offers extraction-free gene expression results from FFPE tissue samples. HTG develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. The company provides extraction-free gene expression profiles that can measure miRNA and mRNA from source material for diagnostic applications. It also provides endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support, and ingenuity IPA data analysis services to pharmaceutical clients. HTG is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company HTG Molecular Diagnostics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents 

Table of Contents 2
List of Tables 4
List of Figures 4
HTG Molecular Diagnostics, Inc. Company Snapshot 5
HTG Molecular Diagnostics, Inc. Company Overview 5
Key Information 5
HTG Molecular Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 6
HTG Molecular Diagnostics, Inc. Pipeline Analysis Overview 8
Key Facts 8
HTG Molecular Diagnostics, Inc. - Major Products and Services 9
HTG Molecular Diagnostics, Inc. Pipeline Products by Development Stage 10
HTG Molecular Diagnostics, Inc. Pipeline Products Overview 12
Companion Diagnostic Test - B-Cell Malignancy 12
Companion Diagnostic Test - B-Cell Malignancy Product Overview 12
COPD Risk Stratification Test 13
COPD Risk Stratification Test Product Overview 13
Diagnostic Test - Breast Cancer 14
Diagnostic Test - Breast Cancer Product Overview 14
Diagnostic Test - Lung Cancer 15
Diagnostic Test - Lung Cancer Product Overview 15
Diagnostic Test - Lymphoma 16
Diagnostic Test - Lymphoma Product Overview 16
Diagnostic Test - Melanoma 17
Diagnostic Test - Melanoma Product Overview 17
Heart Transplant Rejection Blood Test 18
Heart Transplant Rejection Blood Test Product Overview 18
HTG Edge System 19
HTG Edge System Product Overview 19
HTG EdgeSeq 20
HTG EdgeSeq Product Overview 20
HTG Molecular Diagnostics, Inc. - Key Competitors 21
HTG Molecular Diagnostics, Inc. - Key Employees 22
HTG Molecular Diagnostics, Inc. - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
HTG Molecular Diagnostics, Inc., Recent Developments 24
Jun 17, 2014: HTG Receives US Patent for HTG EdgeSeq Chemistry Coupling Quantitative Nuclease Protection With Next-Generation-Sequencing 24
Jun 10, 2014: HTG Launches an Automated, Sequencing-Based miRNA Whole Transcriptome Digital Gene Expression Assay for Challenging Sample Types 24
Sep 25, 2013: The PROOF Centre of Excellence Partners With HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test 24
Sep 25, 2013: The PROOF Centre of Excellence Partners With HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test 25
Sep 04, 2013: NIH Awards HTG Molecular Additional $1.01M to Continue Development of Targeted Sequencing Product Concept 26
Jul 02, 2013: HTG Launches Two Multiplexed Gene Expression Assays for Use on Award-Winning HTG Edge System 26
Jun 24, 2013: HTG Molecular Diagnosticss Edge System Wins 2013 Silver Medical Design Excellence Award 27
Oct 18, 2012: HTG Molecular To Unveil Edge System At AMP Conference 27
Jul 30, 2012: HTG Molecular Diagnostics Achieves ISO 13485:2003 Certification 27
Sep 06, 2011: HTG To Present Molecular Diagnostics Technology Platform At ADAPT Conference 28

Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Table


HTG Molecular Diagnostics, Inc., Key Facts 5
HTG Molecular Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 6
HTG Molecular Diagnostics, Inc. Pipeline Products by Equipment Type 6
HTG Molecular Diagnostics, Inc. Pipeline Products by Indication 7
HTG Molecular Diagnostics, Inc., Key Facts 8
HTG Molecular Diagnostics, Inc., Major Products and Services 9
HTG Molecular Diagnostics, Inc. Number of Pipeline Products by Development Stage 10
HTG Molecular Diagnostics, Inc. Pipeline Products Summary by Development Stage 11
Companion Diagnostic Test - B-Cell Malignancy - Product Status 12
Companion Diagnostic Test - B-Cell Malignancy - Product Description 12
COPD Risk Stratification Test - Product Status 13
COPD Risk Stratification Test - Product Description 13
Diagnostic Test - Breast Cancer - Product Status 14
Diagnostic Test - Breast Cancer - Product Description 14
Diagnostic Test - Lung Cancer - Product Status 15
Diagnostic Test - Lung Cancer - Product Description 15
Diagnostic Test - Lymphoma - Product Status 16
Diagnostic Test - Lymphoma - Product Description 16
Diagnostic Test - Melanoma - Product Status 17
Diagnostic Test - Melanoma - Product Description 17
Heart Transplant Rejection Blood Test - Product Status 18
Heart Transplant Rejection Blood Test - Product Description 18
HTG Edge System - Product Status 19
HTG Edge System - Product Description 19
HTG EdgeSeq - Product Status 20
HTG EdgeSeq - Product Description 20
HTG Molecular Diagnostics, Inc., Key Employees 22

List of Chart


HTG Molecular Diagnostics, Inc. Pipeline Products by Equipment Type 7
HTG Molecular Diagnostics, Inc. Pipeline Products by Development Stage 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *